CS
KALA icon

Credit Suisse’s KALA BIO KALA Stock Holding History

Credit Suisse’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– – – 4161
2022
Q2 		– Hold
0
– – – 4127
2021
Q4 		– Sell
-7
Closed -$49K – 4598
2021
Q3 		$49K Sell
7
-1
-13% -$8.63K ﹤0.01% 4348
2021
Q2 		$100K Hold
8
– – ﹤0.01% 4365
2021
Q1 		$127K Sell
8
-8
-50% -$156K ﹤0.01% 4174
2020
Q4 		$267K Buy
16
+6
+60% +$113K ﹤0.01% 4019
2020
Q3 		$183K Buy
10
+2
+25% +$46K ﹤0.01% 3852
2020
Q2 		$218K Buy
+8
New +$227K ﹤0.01% 3705

Other funds holding KALA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse's KALA Position: Q3 2022 in Review

Credit Suisse held its KALA BIO (KALA) position steady in Q3 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4161.

Credit Suisse first reported a position in KALA in Q2 2020 and has held it in 6 quarters since. The position peaked at $267K in Q4 2020. 53 funds tracked by Wall St. Rank hold KALA as of Q3 2022.

  • Credit Suisse held 0 shares of KALA BIO worth $0 as of Q3 2022.
  • Credit Suisse left its KALA BIO share count unchanged in Q3 2022.
  • KALA BIO made up ﹤0.01% of Credit Suisse's portfolio in Q3 2022, its #4161 holding.
  • Credit Suisse first reported a position in KALA BIO in Q2 2020 and has held it in 6 quarters since.
  • Credit Suisse's KALA BIO position peaked at $267K in Q4 2020.
  • 53 funds tracked by Wall St. Rank held KALA BIO as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.